Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-17-056783

Co-Chief Executive Officer gave up 1,762 shares (to pay taxes)

  • Co-Chief Executive Officer acquired 4,688 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
MOHANTY ADITYA P. Co-Chief Executive Officer 2017-10-10 Option exercise +4,688 94,384 D
MOHANTY ADITYA P. Co-Chief Executive Officer 2017-10-10 Shares withheld for taxes −1,762 $2.81 $4,951 92,622 D
Derivatives
MOHANTY ADITYA P. Co-Chief Executive Officer 2017-10-10 Option exercise · Restricted Stock Units −4,688 46,875 D
Loading xslF345X03/doc4.xml…